Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214227 · ClinicalTrials.gov registry record
ATM Variants in Radiotherapy Patients
A clinical trial of Radiotherapy, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT00214227 is a study of Radiotherapy that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 60 participants, below the 88-participant average among 4 other Radiotherapy trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00214227, a study of Radiotherapy, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the baseline incidence of variant alleles in the ATM and/or other DNA repair genes present in the Native American population versus the non-Native American population. It is thought that a higher baseline incidence of the variant alleles in the ATM gene may correlate to higher rates and higher grades of radiation toxicities noted in the Native American population.
Conditions Studied
Study Locations (1)
Wisconsin
- University of Wisconsin Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00214227
The ClinicalTrials.gov registry entry for NCT00214227 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 88-participant average among 4 other Radiotherapy trials with a reported enrollment target (32% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiotherapy appearing as the primary indexed condition, and to 0 interventions.
NCT00214227 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00214227 about?
NCT00214227 is a clinical study titled "ATM Variants in Radiotherapy Patients". The purpose of this study is to compare the baseline incidence of variant alleles in the ATM and/or other DNA repair genes present in the Native American population versus the non-Native American population. It is thought that a higher baseline incidence of the variant alleles in the ATM gene may co...
What is the current status of trial NCT00214227?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-12. Estimated completion is 2013-01.
What conditions does trial NCT00214227 study?
This clinical trial studies the following conditions: Radiotherapy.
Who is sponsoring clinical trial NCT00214227?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00214227 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiotherapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
RECRUITING · Phase 2
-
Serial MRI Scans During Radiation Therapy
RECRUITING · NA
-
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
ACTIVE NOT RECRUITING · Phase 1
-
T2* MRI Analysis for Sarcoma
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.